The US pain management devices market is estimated to grow at a CAGR of more than 6% during the forecast period. The factors that are contributing to the market growth include increased R&D and high healthcare expenditure. The region has a well-developed healthcare infrastructure and a large number of biotech companies. Further, the growth of the US pain management devices market is attributed to the increasing prevalence of chronic diseases such as cancer. After the treatment of cancer, the patients experience cancer pain arises due to cancer therapy. This augments the demand for pain management devices to relieve the patients from suffering, which in turn fuel the market growth.

Request a Free Report on Sample of US Pain Management Devices Market @ https://www.omrglobal.com/request-sample/us-pain-management-devices-market

The US pain management devices market is segmented on the basis of type and application. Based on type, the market is segmented into an analgesic infusion pump, ablation devices, and neurostimulators. Neurostimulators held the largest share in 2018. Neurostimulators can be used for the treatment of numerous conditions, such as post-surgical pain, Parkinson’s disease, low back pain, essential tremor and migraine, and muscle weakness. On the basis of application, the market is into cancer pain, neuropathic pain, musculoskeletal pain, facial and migraine pain and trauma. Neuropathic pain held the largest share in 2018.

A full Report of US Pain Management Devices Market Available at https://www.omrglobal.com/industry-reports/us-pain-management-devices-market

Moreover, the report covers the analysis of several players operating in the US pain management devices market. Some of the major players include Abbot Laboratories Inc., Baxter International Inc., Becton, Dickinson and Company, BioElectronics Corp., Boston Scientific Corp., and others. In May 2018, BioElectronics Corp. received the US FDA approval for its ActiPatch medical device for the indication- “adjunctive treatment of musculoskeletal pain. The ActiPatch was already FDA-cleared for over-the-counter treatment of pain from knee osteoarthritis and plantar fasciitis in 2017. This clearance expanded these indications to cover all musculoskeletal pain complaints.

US Pain Management Devices Market Segmentation

By Type

• Analgesic Infusion Pumps
• Ablation Devices
• Neurostimulators

By Application

• Cancer Pain
• Neuropathic Pain
• Musculoskeletal Pain
• Facial and Migraine Pain
• Trauma

Company Profiles

• Abbott Laboratories Inc.
• B. Braun Melsungen AG
• Baxter International Inc.
• Biomedical Research Ltd.
• Becton, Dickinson, and Company
• Boston Scientific Corp.
• Medtronic PLC
• Stryker Corp.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/us-pain-management-devices-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. AnuragTiwari
Email: [email protected]
Contact no: +1 646-755-7667, +91 780-304-0404
Visit for https://www.omrglobal.com/industry-reports/pain-management-devices-market